Partner Content Partner Content Less than 3 weeks to SMi's 3rd Annual Drug Discovery Chemist... 3 weeks to SMi's 3rd Annual Drug Discovery Chemistry
Partner Content Partner Content Drug Discovery Chemistry - Speaker Interviews with GSK &... Exclusive Speaker Interviews Released with GSK & Roche
Events Partner Content SMi's 3rd Annual Drug Discovery Chemistry Conference SMi's 3rd Annual Drug Discovery Chemistry
Partner Content Partner Content SMi’s Drug Discovery Chemistry announces key industry speake... SMi’s Drug Discovery Chemistry brochure available
R&D Boosting clinical trial productivity to prove Eroom wrong According to Eroom’s law, drug discovery becomes slower and costlier over time. And the data are, at least in part, bearing that out.
News GSK collaborates on AI-driven drug design with Cloud Pharmac... GlaxoSmithKline (GSK) is set to apply artificial intelligence (AI) technology to improve its drug discovery efforts through a collaboration with Cloud Pharmaceuticals.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.